Next Article in Journal
Stride Length Predicts Adverse Clinical Events in Older Adults: A Systematic Review and Meta-Analysis
Next Article in Special Issue
Attitudes towards Trusting Artificial Intelligence Insights and Factors to Prevent the Passive Adherence of GPs: A Pilot Study
Previous Article in Journal
Twenty Years of GH Treatment in Adults with Prader-Willi Syndrome
Previous Article in Special Issue
Usefulness of Respiratory Mechanics and Laboratory Parameter Trends as Markers of Early Treatment Success in Mechanically Ventilated Severe Coronavirus Disease: A Single-Center Pilot Study
Article

Areas of Interest and Attitudes towards the Pharmacological Treatment of Attention Deficit Hyperactivity Disorder: Thematic and Quantitative Analysis Using Twitter

1
Service of Psychiatry and Mental Health, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain
2
Department of Medicine and Medical Specialities, University of Alcala, 28805 Alcala de Henares, Spain
3
Department of Endocrinology and Clinical Nutrition, Hospital Universitario Infanta Leonor, 28031 Madrid, Spain
4
Department of Psychiatry, University Hospital “Principe de Asturias”, 28805 Alcala de Henares, Spain
5
CIBERSAM (Biomedical Research Networking Centre in Mental Health), 22807 Madrid, Spain
6
Institute Ramon y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain
7
Louis A Faillace Department of Psychiatry and Behavioral Science, The University of Texas Health Science Centre at Houston, Houston, TX 77054, USA
8
Department of Legal Medicine, Psychiatry and Pathology, Complutense University, 28040 Madrid, Spain
9
Department of Surgery, Medical and Social Sciences, Faculty of Medicine and Health Sciences, University of Alcalá, 28805 Alcala de Henares, Spain
10
Biomedical Institute for Liver and Gut Diseases (CIBEREHD), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, 28029 Madrid, Spain
11
Service of Internal Medicine and Rheumatology, Autoimmune Diseases University Hospital “Principe de Asturias”, 28805 Alcala de Henares, Spain
*
Author to whom correspondence should be addressed.
Academic Editor: Vida Abedi
J. Clin. Med. 2021, 10(12), 2668; https://doi.org/10.3390/jcm10122668
Received: 15 March 2021 / Revised: 8 June 2021 / Accepted: 13 June 2021 / Published: 17 June 2021
We focused on tweets containing hashtags related to ADHD pharmacotherapy between 20 September and 31 October 2019. Tweets were classified as to whether they described medical issues or not. Tweets with medical content were classified according to the topic they referred to: side effects, efficacy, or adherence. Furthermore, we classified any links included within a tweet as either scientific or non-scientific. We created a dataset of 6568 tweets: 4949 (75.4%) related to stimulants, 605 (9.2%) to non-stimulants and 1014 (15.4%) to alpha-2 agonists. Next, we manually analyzed 1810 tweets. In the end, 481 (48%) of the tweets in the stimulant group, 218 (71.9%) in the non-stimulant group and 162 (31.9%) in the alpha agonist group were considered classifiable. Stimulants accumulated the majority of tweets. Notably, the content that generated the highest frequency of tweets was that related to treatment efficacy, with alpha-2 agonist-related tweets accumulating the highest proportion of positive consideration. We found the highest percentages of tweets with scientific links in those posts related to alpha-2 agonists. Stimulant-related tweets obtained the highest proportion of likes and were the most disseminated within the Twitter community. Understanding the public view of these medications is necessary to design promotional strategies aimed at the appropriate population. View Full-Text
Keywords: ADHD; social media; Twitter; pharmacotherapy; stimulants; alpha-2-adrenergic agonists; non-stimulants ADHD; social media; Twitter; pharmacotherapy; stimulants; alpha-2-adrenergic agonists; non-stimulants
Show Figures

Figure 1

MDPI and ACS Style

Alvarez-Mon, M.A.; de Anta, L.; Llavero-Valero, M.; Lahera, G.; Ortega, M.A.; Soutullo, C.; Quintero, J.; Asunsolo del Barco, A.; Alvarez-Mon, M. Areas of Interest and Attitudes towards the Pharmacological Treatment of Attention Deficit Hyperactivity Disorder: Thematic and Quantitative Analysis Using Twitter. J. Clin. Med. 2021, 10, 2668. https://doi.org/10.3390/jcm10122668

AMA Style

Alvarez-Mon MA, de Anta L, Llavero-Valero M, Lahera G, Ortega MA, Soutullo C, Quintero J, Asunsolo del Barco A, Alvarez-Mon M. Areas of Interest and Attitudes towards the Pharmacological Treatment of Attention Deficit Hyperactivity Disorder: Thematic and Quantitative Analysis Using Twitter. Journal of Clinical Medicine. 2021; 10(12):2668. https://doi.org/10.3390/jcm10122668

Chicago/Turabian Style

Alvarez-Mon, Miguel A., Laura de Anta, Maria Llavero-Valero, Guillermo Lahera, Miguel A. Ortega, Cesar Soutullo, Javier Quintero, Angel Asunsolo del Barco, and Melchor Alvarez-Mon. 2021. "Areas of Interest and Attitudes towards the Pharmacological Treatment of Attention Deficit Hyperactivity Disorder: Thematic and Quantitative Analysis Using Twitter" Journal of Clinical Medicine 10, no. 12: 2668. https://doi.org/10.3390/jcm10122668

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop